Sort
51,593 grants matching “hepatitis”
African American Female Drug Users: HIV, Health Disparities, & Criminality
$573,161Carrie Beth Oser · University Of Kentucky · R01 · FY2009 · DA
GENETIC ANALSIS OF CELL TYPE SPECIFIC FUNCTIONS
$573,129Fred Hutchinson Cancer Research Center · R01 · FY2000 · GM
Sulfur Amino Acid Metabolism in NAFLD
$573,100Satish C Kalhan · Cleveland Clinic Lerner Com-Cwru · R01 · FY2010 · DK
ENTEROHEPATIC LIPID FLUX AND APOPROTEIN BIOSYNTHESIS.
$573,069Nicholas Davidson · Washington University · R37 · FY2009 · HL
2/3 COMpAAAS Tripartite: ART-CC, KP, and VA
$573,066Michael J Silverberg · Kaiser Foundation Research Institute · U01 · FY2021 · AA
Exercise Dose-Response Effects in Prediabetes: Responses and Mechanisms
$573,018William E Kraus · Duke University · R01 · FY2012 · DK
Physiological Ramifications of Chorionic Somatomammotropin Deficiency
$572,997Paul Joseph Rozance · University Of Colorado Denver · R01 · FY2021 · HD
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for HCV Trial
$572,986Jason S Haukoos · Denver Health And Hospital Authority · R01 · FY2020 · DA
Roles of microbiota-mediated hepatocarcinogenesis
$572,982Xin Wei Wang · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Corticosteroid Pharmacokinetics and Pharmacodynamics
$572,975William J Jusko · State University Of New York At Buffalo · R37 · FY2007 · GM
Corticosteroid Pharmacokinetics and Pharmacodynamics
$572,928William J Jusko · State University Of New York At Buffalo · R37 · FY2008 · GM
A Rapid Multiplexed Assay for the Diagnosis of Viral Hepatitis at the Point of Care
$572,902Johann Desa · Instadiagnostics, Inc. · R44 · FY2020 · PS
Mechanism of Renal Cortical Insulin Resistance
$572,800Gerald I Shulman · Yale University · R01 · FY2022 · DK
Mechanism of Renal Cortical Insulin Resistance
$572,800Gerald I Shulman · Yale University · R01 · FY2025 · DK
Mechanism of Renal Cortical Insulin Resistance
$572,800Gerald I Shulman · Yale University · R01 · FY2023 · DK
Epigenetic markers of severity in nonalcoholic fatty liver disease
$572,790Johanna K Distefano · National Jewish Health · R01 · FY2016 · DK
Endotoxin Detoxification
$572,772Robert Munford · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Maternal Obesity and Pediatric NAFLD: Fetal Origins and Long-term outcomes in Non Human Primates
$572,644Jacob E Friedman · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · DK
Brain Circuits Involved in the Sympathetic Control of the Liver
$572,605Andrea Zsombok · Tulane University Of Louisiana · R01 · FY2023 · DK
Brain Circuits Involved in the Sympathetic Control of the Liver
$572,605Andrea Zsombok · Tulane University Of Louisiana · R01 · FY2022 · DK
Regulation of lipid metabolism in pulmonary Type 2 cells
$572,549Itsaso Garcia-Arcos · Suny Downstate Medical Center · R01 · FY2025 · HL
A randomised study of interferon-free treatment for recently acquired hepatitis C in people who inject drugs and people with HIV coinfection (the REACT Study)
$572,496Gail Matthews · University Of New South Wales · R01 · FY2019 · DA
Reducing Youth Drug Related HIV/STD Risk in Thailand
$572,427Johns Hopkins University · R01 · FY2001 · DA
Bariatic Surgery: Outcomes & Impact on Pathophysiology
$572,363Paul David Berk · Columbia University Health Sciences · U01 · FY2006 · DK
Quantification of Liver Fibrosis with MRI and Deep Learning
$572,327Lili He · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · EB